Search

everythinglearnresearchcommunity

for

Search:↓

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

The herbal preparation may help manage alopecia by reducing inflammation and boosting the immune response.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

The formulated gel is a promising treatment for alopecia areata.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Tofacitinib taken by mouth helps treat hair loss in children.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Oral tofacitinib successfully treated total body hair loss in one patient.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

The BIOMAP glossary standardizes data to improve research on atopic dermatitis and psoriasis.

Antibodies help identify glycoproteins in normal skin and tumor cells.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.